BIOMAT Database Logo BIOMAT Database Logo

The 'immunologic advantage' of HIV-exposed seronegative individuals. 2009

Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D009626 Terminology as Topic Works about the terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area. Etymology,Nomenclature as Topic,Etymologies
D004198 Disease Susceptibility A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases. Diathesis,Susceptibility, Disease,Diatheses,Disease Susceptibilities,Susceptibilities, Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D018023 HIV Seronegativity Immune status consisting of non-production of HIV antibodies, as determined by various serological tests. HTLV-III Seronegativity,HIV Seronegativities,HTLV III Seronegativity,HTLV-III Seronegativities,Seronegativities, HIV,Seronegativities, HTLV-III,Seronegativity, HIV,Seronegativity, HTLV-III

Related Publications

Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
The 'immunologic advantage' of HIV-exposed seronegative individuals.
July 2009, AIDS (London, England),
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Mucosal immunoglobulin A in HIV-exposed seronegative individuals.
November 2012, AIDS (London, England),
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Immunologic profile of highly exposed yet HIV type 1-seronegative men.
September 2002, AIDS research and human retroviruses,
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
TLR activation pathways in HIV-1-exposed seronegative individuals.
March 2010, Journal of immunology (Baltimore, Md. : 1950),
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.
February 2006, Current HIV/AIDS reports,
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
March 1996, AIDS research and human retroviruses,
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein.
June 2013, AIDS (London, England),
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.
March 2011, Blood,
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals.
September 2016, Journal of acquired immune deficiency syndromes (1999),
Masaaki Miyazawa, and Lucia Lopalco, and Francesco Mazzotta, and Sergio Lo Caputo, and Francisco Veas, and Mario Clerici, and
Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.
April 2011, Journal of virology,
Copied contents to your clipboard!